Significantly, it was revealed that miR-210 exerts a negative regulatory effect on EFNA3 expression and actively participates in the PI3K/AKT/VEGFA or Wnt/β-catenin/RHOA pathways, thereby promoting tumour angiogenesis and cellular permeability. This evidence concerns the gene EFNA3 and neoplasm.